FYERS
Home
/
Stocks
/
Profit Loss
/
Ind-Swift Laboratories Profit & Loss

Ind-Swift Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018
₹240 Cr₹191 Cr₹170 Cr₹151 Cr₹159 Cr₹158 Cr₹142 Cr₹129 Cr₹148 Cr₹147 Cr₹529 Cr₹288 Cr₹290 Cr₹310 Cr₹304 Cr₹313 Cr₹310 Cr₹280 Cr₹307 Cr₹247 Cr₹236 Cr₹250 Cr₹227 Cr₹226 Cr₹228 Cr₹210 Cr₹192 Cr₹204 Cr₹192 Cr₹188 Cr₹194 Cr₹198 Cr₹167 Cr₹185 Cr
₹8 Cr₹8 Cr₹2 Cr₹28 Cr₹12 Cr₹9 Cr-₹31 L₹17 Cr₹17 Cr₹43 Cr₹71 Cr₹7 Cr₹7 Cr₹6 Cr₹10 Cr₹8 Cr₹8 Cr₹7 Cr₹21 Cr₹8 Cr₹7 Cr₹6 Cr₹3 Cr₹9 Cr₹5 Cr₹6 Cr₹12 Cr₹8 Cr₹11 Cr₹6 Cr₹6 Cr₹8 Cr₹13 Cr₹4 Cr
₹248 Cr₹199 Cr₹172 Cr₹178 Cr₹171 Cr₹167 Cr₹142 Cr₹145 Cr₹166 Cr₹190 Cr₹600 Cr₹295 Cr₹297 Cr₹316 Cr₹314 Cr₹321 Cr₹318 Cr₹288 Cr₹328 Cr₹255 Cr₹243 Cr₹256 Cr₹229 Cr₹235 Cr₹234 Cr₹216 Cr₹204 Cr₹211 Cr₹202 Cr₹193 Cr₹200 Cr₹206 Cr₹181 Cr₹189 Cr
₹203 Cr₹166 Cr₹157 Cr₹156 Cr₹158 Cr₹156 Cr₹154 Cr₹141 Cr₹151 Cr₹159 Cr₹457 Cr₹249 Cr₹237 Cr₹264 Cr₹250 Cr₹274 Cr₹268 Cr₹243 Cr₹352 Cr₹216 Cr₹193 Cr₹213 Cr₹213 Cr₹198 Cr₹199 Cr₹187 Cr₹178 Cr₹187 Cr₹185 Cr₹170 Cr₹185 Cr₹189 Cr₹162 Cr₹180 Cr
₹53 Cr₹41 Cr₹23 Cr₹32 Cr₹19 Cr₹18 Cr-₹5 Cr₹10 Cr₹20 Cr₹37 Cr₹162 Cr₹59 Cr₹73 Cr₹66 Cr₹74 Cr₹62 Cr₹66 Cr₹60 Cr₹58 Cr₹61 Cr₹63 Cr₹57 Cr₹44 Cr₹57 Cr₹55 Cr₹49 Cr₹48 Cr₹47 Cr₹40 Cr₹45 Cr₹43 Cr₹43 Cr₹45 Cr₹34 Cr
₹1 Cr₹71 L-₹2 Cr₹67 L₹2 Cr₹1 Cr-₹27 Cr₹10 Cr₹10 Cr₹10 Cr₹3 Cr₹21 Cr₹21 Cr₹20 Cr₹22 Cr₹22 Cr₹24 Cr₹24 Cr₹23 Cr₹24 Cr₹24 Cr₹24 Cr₹24 Cr₹26 Cr₹25 Cr₹25 Cr₹21 Cr₹29 Cr₹29 Cr₹28 Cr₹27 Cr₹22 Cr₹22 Cr₹5 Cr
₹43 Cr₹33 Cr₹12 Cr₹16 Cr₹10 Cr₹10 Cr₹230 Cr-₹7 Cr₹5 Cr₹29 Cr₹527 Cr₹24 Cr₹39 Cr₹32 Cr₹16 Cr₹24 Cr₹26 Cr₹20 Cr-₹47 Cr₹16 Cr₹25 Cr₹19 Cr-₹8 Cr₹12 Cr₹10 Cr₹5 Cr₹4 Cr-₹5 Cr-₹12 Cr-₹6 Cr-₹5 Cr₹40 Cr₹3 Cr₹28 Cr
₹34 Cr₹25 Cr₹15 Cr₹10 Cr₹8 Cr₹9 Cr₹222 Cr-₹6 Cr₹5 Cr₹29 Cr₹494 Cr₹20 Cr₹32 Cr₹17 Cr-₹25 Cr₹28 Cr₹25 Cr₹20 Cr-₹61 Cr₹16 Cr₹24 Cr₹19 Cr-₹29 Cr₹12 Cr₹10 Cr₹5 Cr₹3 Cr-₹5 Cr-₹12 Cr-₹6 Cr-₹25 Cr₹40 Cr₹3 Cr₹28 Cr

Share Price Live Stats

Open (₹)345.50
Volume (₹)6.85 L
High (₹)373.00
Upper Circuit412.50
Low (₹)345.50
Lower Circuit275.00
Prev Close343.75
52W High (₹)426.60
Price370.55
52W Low (₹)87.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)3028.59 Cr
Div. Yield (%)0.00
PE Ratio36.25
Debt to Equity0.01
Price to Book0.83
Book Value159.28
EPS (TTM)9.46
Face Value10.00
ROE (%)3.47

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
INDSWFTLABNSE
LTP
1W Low
1W High
Market cap (₹)
1773.4-4.3 (-0.24%)
1722
1810.40
4,25,150Cr
10037.5+257.5 (2.63%)
9863
10067
2,66,265Cr
4738.5+125.1 (2.71%)
4553
4738.50
1,76,301Cr
2323.8-81.7 (-3.40%)
2252.40
2441.90
1,25,352Cr
1188.1-57.4 (-4.61%)
1182.40
1266.60
1,23,591Cr
1374+22 (1.63%)
1336.70
1376.70
1,14,351Cr
1402+23.1 (1.68%)
1364.60
1402
1,12,474Cr
2537.9+45.1 (1.81%)
2457.90
2540
1,02,315Cr
1705+23.6 (1.40%)
1656.20
1724.60
97,757Cr
2008.6-2.4 (-0.12%)
1988.90
2062.10
92,007Cr
370.55+2.35 (0.64%)
338.85
374.75
3,029Cr
Empty box

No content available